Natural Capsules Limited (NSE:NATCAPSUQ)
142.80
+2.40 (1.71%)
Jul 22, 2026, 3:29 PM IST
Natural Capsules Revenue
In the fiscal year ending March 31, 2026, Natural Capsules had annual revenue of 1.87B INR with 10.64% growth. Natural Capsules had revenue of 584.53M in the quarter ending March 31, 2026, with 29.98% growth.
Revenue
1.87B
Revenue Growth
+10.64%
P/S Ratio
0.79
Revenue / Employee
3.04M
Employees
619
Market Cap
1.47B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.87B | 179.99M | 10.64% |
| Mar 31, 2025 | 1.69B | 137.86M | 8.87% |
| Mar 31, 2024 | 1.55B | -169.54M | -9.84% |
| Mar 31, 2023 | 1.72B | 373.09M | 27.62% |
| Mar 31, 2022 | 1.35B | 555.52M | 69.86% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sigachi Industries | 4.86B |
| Balaxi Pharmaceuticals | 2.70B |
| Valiant Laboratories | 2.37B |
| Bafna Pharmaceuticals | 1.51B |
| Vaishali Pharma | 1.09B |
| Alpa Laboratories | 1.06B |
| Par Drugs and Chemicals | 1.04B |
| Brooks Laboratories | 857.38M |